Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Bloodstream Infection Testing Market to reach USD 980.01 million by the end of 2030.

Global Bloodstream Infection Testing Market Size Study & Forecast, by Product (Reagents & Consumables, Instruments), by Sample Type (Whole Blood, Blood Culture), by Technology (PCR, Mass Spectroscopy, In Situ Hybridization, Others), by End-use (Hospitals & Diagnostic Centers, Custom Laboratory Service Providers, Others), and Regional Analysis, 2023-2030

Product Code: HLSMD-70788422
Publish Date: 20-12-2023
Page: 200

Global Bloodstream Infection Testing Market is valued at approximately USD 689.13 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2030. Bloodstream infection testing, also known as blood culture testing, is a medical diagnostic procedure that is used to detect the presence of microorganisms, such as bacteria, fungi, and sometimes viruses, in a patient’s bloodstream. It is a critical diagnostic tool in clinical medicine for identifying and managing sepsis, a severe and potentially life-threatening condition that occurs when the body’s response to infection causes harm to its own tissues and organs. This plays a vital role in investigating the bacteria and pathogens accountable for bloodstream infections. There is a heightened risk of infectious diseases spreading particularly in densely populated regions with limited hygiene practices, posing a significant threat to public health. This presents a challenge for public health management, necessitating efficient diagnostic approaches to identify and contain these infections. The global rise in infectious diseases and the growing awareness and focus on infection control stand out as key drivers propelling the market growth during the estimated period.

In addition, the rise in the number of blood donation campaigns is playing a major role in supporting the market growth on a global scale. Governments around the world are implementing initiatives to reduce the incidence of healthcare-associated infections. These initiatives are driving the demand for bloodstream infection testing in hospitals and other healthcare settings. For instance, in August 2022, The U.S. Department of Health and Human Services (HHS) unveiled an initiative to boost blood and plasma donations. This initiative focuses on raising public consciousness about the significance of blood and plasma donations and fostering a culture of consistent contributions among Americans. Also, in November 2021, the Emirates Health Services (EHS) launched a Blood Donation Campaign with the objective of fostering community engagement and nurturing a culture of generosity. This initiative seeks to increase awareness about the significance of blood donation and to address the requirements of patients. Thus, this initiative promotes blood donation which further leads to an emphasis on infection control and prevention in healthcare settings, especially in the wake of healthcare-associated infections. Initiatives to curb the overuse and misuse of antibiotics, which are closely tied to the management of bloodstream infections, promote the use of targeted testing. Moreover, the rise in the development of rapid point-of-care testing solutions, as well as the increasing use of invasive medical devices presents various lucrative opportunities over the forecast years. However, the high diagnosis cost and lower investments in underdeveloped countries are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Bloodstream Infection Testing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increased disposable income, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and a growing number of strategic endeavors and product launches by major industry players. Additionally, the surge in demand for rapid diagnostic tests, as well as growing awareness of healthcare-associated infection is further propelling the market demand across the region. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing investment in technological advancements and increasing number of government initiatives are significantly propelling the market demand across the region. Also, the increasing prevalence of chronic diseases, the rising aging population, along with shift towards patient-centered care and personalized medicine are further promoting the regional market expansion.

Major market players included in this report are:
BioMérieux SA
Becton, Dickinson and Company
Cepheid.
Seegene Inc.
T2 Biosystems, Inc.
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Luminex Corporation.
Bruker
Accelerate Diagnostics, Inc.

Recent Developments in the Market:
Ø In October 2022, BD, a renowned global medical technology firm, partnered with Magnolia Medical Technologies, Inc., in a commercial agreement. This agreement is focusing on aiding U.S. hospitals in minimizing blood culture contamination, elevating the precision of testing, and, ultimately, enhancing clinical outcomes.
Ø In July 2022, T2 Biosystems, Inc., a prominent player in the early detection of antibiotic resistance genes and pathogens causing sepsis, was granted approval by the U.S. Food and Drug Administration (FDA) for its T2Lyme Panel. This panel allows healthcare providers to expedite appropriate treatment for patients, thereby mitigating the potential adverse effects of treatment and reducing antibiotic overuse.

Global Bloodstream Infection Testing Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Sample Type, Technology, End-use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Reagents & Consumables
Instruments

By Sample Type:
Whole Blood
Blood Culture

By Technology:
PCR
Mass Spectroscopy
In Situ Hybridization
Others

By End-use:
Hospitals & Diagnostic Centers
Custom Laboratory Service Providers
Academic & Research Institutes
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Bloodstream Infection Testing Market, by Region, 2020-2030 (USD Million)
1.2.2. Bloodstream Infection Testing Market, by Product, 2020-2030 (USD Million)
1.2.3. Bloodstream Infection Testing Market, by Sample Type, 2020-2030 (USD Million)
1.2.4. Bloodstream Infection Testing Market, by Technology, 2020-2030 (USD Million)
1.2.5. Bloodstream Infection Testing Market, by End-use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bloodstream Infection Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bloodstream Infection Testing Market Dynamics
3.1. Bloodstream Infection Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing burden of infectious diseases
3.1.1.2. Rising number of blood donations campaign
3.1.2. Market Challenges
3.1.2.1. High diagnosis cost
3.1.2.2. Lower investments in underdeveloped countries
3.1.3. Market Opportunities
3.1.3.1. Rise in the development of rapid point-of-care testing solutions
3.1.3.2. Increasing use of invasive medical devices
Chapter 4. Global Bloodstream Infection Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Bloodstream Infection Testing Market, by Product
5.1. Market Snapshot
5.2. Global Bloodstream Infection Testing Market by Product, Performance – Potential Analysis
5.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Bloodstream Infection Testing Market, Sub Segment Analysis
5.4.1. Reagents & Consumables
5.4.2. Instruments
Chapter 6. Global Bloodstream Infection Testing Market, by Sample Type
6.1. Market Snapshot
6.2. Global Bloodstream Infection Testing Market by Sample Type, Performance – Potential Analysis
6.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
6.4. Bloodstream Infection Testing Market, Sub Segment Analysis
6.4.1. Whole Blood
6.4.2. Blood Culture
Chapter 7. Global Bloodstream Infection Testing Market, by Technology
7.1. Market Snapshot
7.2. Global Bloodstream Infection Testing Market by Technology, Performance – Potential Analysis
7.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
7.4. Bloodstream Infection Testing Market, Sub Segment Analysis
7.4.1. PCR
7.4.2. Mass Spectroscopy
7.4.3. In Situ Hybridization
7.4.4. Others
Chapter 8. Bloodstream Infection Testing Market, by End-use
8.1. Market Snapshot
8.2. Global Bloodstream Infection Testing Market by End-use, Performance – Potential Analysis
8.3. Global Bloodstream Infection Testing Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4. Bloodstream Infection Testing Market, Sub Segment Analysis
8.4.1. Hospitals & Diagnostic Centers
8.4.2. Custom Laboratory Service Providers
8.4.3. Academic & Research Institutes
8.4.4. Others
Chapter 9. Global Bloodstream Infection Testing Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Bloodstream Infection Testing Market, Regional Market Snapshot
9.4. North America Bloodstream Infection Testing Market
9.4.1. U.S. Bloodstream Infection Testing Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Sample Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Bloodstream Infection Testing Market
9.5. Europe Bloodstream Infection Testing Market Snapshot
9.5.1. U.K. Bloodstream Infection Testing Market
9.5.2. Germany Bloodstream Infection Testing Market
9.5.3. France Bloodstream Infection Testing Market
9.5.4. Spain Bloodstream Infection Testing Market
9.5.5. Italy Bloodstream Infection Testing Market
9.5.6. Rest of Europe Bloodstream Infection Testing Market
9.6. Asia-Pacific Bloodstream Infection Testing Market Snapshot
9.6.1. China Bloodstream Infection Testing Market
9.6.2. India Bloodstream Infection Testing Market
9.6.3. Japan Bloodstream Infection Testing Market
9.6.4. Australia Bloodstream Infection Testing Market
9.6.5. South Korea Bloodstream Infection Testing Market
9.6.6. Rest of Asia Pacific Bloodstream Infection Testing Market
9.7. Latin America Bloodstream Infection Testing Market Snapshot
9.7.1. Brazil Bloodstream Infection Testing Market
9.7.2. Mexico Bloodstream Infection Testing Market
9.8. Middle East & Africa Bloodstream Infection Testing Market
9.8.1. Saudi Arabia Bloodstream Infection Testing Market
9.8.2. South Africa Bloodstream Infection Testing Market
9.8.3. Rest of Middle East & Africa Bloodstream Infection Testing Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. BioMérieux SA
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Becton, Dickinson and Company
10.3.3. Cepheid.
10.3.4. Seegene Inc.
10.3.5. T2 Biosystems, Inc.
10.3.6. F. Hoffmann-La Roche Ltd
10.3.7. Siemens Healthcare GmbH
10.3.8. Luminex Corporation.
10.3.9. Bruker
10.3.10. Accelerate Diagnostics, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now